Behavioral Interventions to Improve Management of Overweight, Obesity, and Diabetes in Patients with Schizophrenia

  • Christine L. McKibbin
  • David Folsom
  • Jonathan Meyer
  • A'verria Sirkin
  • Catherine Loh
  • Laurie Lindamer

The relationship between schizophrenia and diabetes mellitus has been recognized in case reports since the end of the nineteenth century (Holt, Bushe, & Citrome, 2005). More recent data suggest that diabetes, obesity, and the metabolic syndrome are 1.5–2 times more common in patients with schizophrenia than in the general population (American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity, 2004; Henderson, 2005). Although the mechanisms of this relationship are not clearly understood, a combination of genetic and environmental factors (e.g., sedentary lifestyle, poor diet, and side effects of antipsychotic medications) may play a role in the high prevalence of metabolic dysregulation in this population (Citrome, 2004; Cohn, Prud’homme, Streiner, Kameh, & Remington, 2004; Henderson, Cagliero et al., 2006; De Hert et al., 2006; Lamberti et al., 2004; McEvoy et al., 2005). While some increased risk may be attributed to standard risk patterns (i.e., 17–50% of people with schizophrenia have a family history of diabetes; Mukherjee, Schnur, & Reddy, 1989), the high rates of obesity in patients with schizophrenia (Marder et al., 2004) may also contribute to increased risk, due, in part, to the relative weight gain liabilities of second-generation antipsychotics (Newcomer, 2005).


Mental Illness Group Leader Diabetes Management Residential Care Facility Diabetes Knowledge 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27, 596–601.CrossRefGoogle Scholar
  2. Anderson, R. M., Funnell, M. M., Fitgerald, J. T., & Marrero, D. G. (2000). The diabetes empowerment scale: A measure of psychosocial self-efficacy. Diabetes Care, 23, 739–743.CrossRefPubMedGoogle Scholar
  3. Archie, S., Wilson, J. H., Osbourne, S., Hobbs, H., & McNiven, J. (2003). Pilot study: Access to fitness facility and exercise levels in olanzapine-treated patients. Canadian Journal of Psychiatry, 48, 628–632.Google Scholar
  4. Bandura, A. (1986). Social foundations of thought and action: A social cognitive theory. Englewood Cliffs, NJ: Prentice-Hall.Google Scholar
  5. Bandura, A. (1989). Perceived self-efficacy. In V. Mays, G. Albee, & S. Schneider (Eds.), Primary prevention of AIDS: Psychological approaches. Newbury Park, CA: Sage.Google Scholar
  6. Bartels, S. J., Forester, B., Mueser, K. T., Miles, K. M., Dums, A. R., Pratt, S. I., et al. (2004). Enhanced skills training and health care management for older persons with severe mental illness. Community Mental Health Journal, 40, 75–90.CrossRefPubMedGoogle Scholar
  7. Brar, J. S., Ganguli, R., Pandina, G., Turkoz, I., Berry, S., & Mahmoud, R. (2005). Effects of behavior therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry, 66, 205–212.PubMedCrossRefGoogle Scholar
  8. Brown, S., Birtwistle, J., Roe, L., & Thompson, C. (1999). The unhealthy lifestyle of people with schizophrenia. Psychological Medicine, 29, 697–701.CrossRefPubMedGoogle Scholar
  9. Citrome, L. (2004). The increase in risk of diabetes mellitus from exposure to second-generation antipsychotic agents. Drugs Today (Barc), 40, 445–464.CrossRefGoogle Scholar
  10. Cohn, T., Prud’homme, D., Streiner, D., Kameh, H., & Remington, G. (2004). Characterizing coronary heart disease risk in chronic schizophrenia: High prevalence of the metabolic syndrome. Canadian Journal of Psychiatry, 49, 753–760.Google Scholar
  11. Council on Scientific Affairs. (1991). Hispanic health in the United States. Journal of the American Medical Association, 265, 248–252.CrossRefGoogle Scholar
  12. Daumit, G. L., Goldberg, R. W., Anthony, C., Dickerson, F., Brown, C. H., Kreyenbuhl, J., et al. (2005). Physical activity patterns in adults with severe mental illness. Journal of Nervous and Mental Disease, 193, 641–646.CrossRefPubMedGoogle Scholar
  13. Davidson, S., Judd, F., Jolley, D., Hocking, B., Thompson, S., & Hyland, B. (2001). Cardiovascular risk factors for people with mental illness. Australian and New Zealand Journal of Psychiatry, 35, 196–202.CrossRefPubMedGoogle Scholar
  14. De Hert, M. A., van Winkel, R., van Eyck, D., Hanssens, L., Wampers, M., Scheen, A., et al. (2006). Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophrenia Research, 83, 87–93.CrossRefPubMedGoogle Scholar
  15. Dickerson, F. B., Brown, C. H., Daumit, G. L., Lijuan, F., Goldberg, R. W., Wohlheiter, K., et al. (2006). Health status of individuals with serious mental illness. Schizophrenia Bulletin, 32, 584–589.CrossRefPubMedGoogle Scholar
  16. Elyer-Zorrilla, L. T., Heaton, R. K., McAdams, L. A., Zisook, S., & Jeste, D. V. (2000). Cross-sectional study of older outpatients with schizophrenia and healthy comparison subjects: No difference in age-related cognitive decline. American Journal of Psychiatry, 157, 1324–1326.CrossRefGoogle Scholar
  17. Evans, S., Newton, R., & Higgins, S. (2005). Nutritional intervention to prevent weight gain in patients commenced on olanzapine: A randomized controlled trial. Australian and New Zealand Journal of Psychiatry, 39, 479–486.CrossRefPubMedGoogle Scholar
  18. Faulkner, G., Soundy, A. A., & Lloyd, K. (2003). Schizophrenia and weight management: A systematic review of interventions to control weight. Acta Psychiatrica Scandinavica, 108, 324–332.CrossRefPubMedGoogle Scholar
  19. Fitzgerald, J. T., Davis, W. K., Connell, C. M., Hess, G. E., Funnell, M. M., & Hiss, R. G. (1996). Development and validation of the diabetes care profile. Evaluation and the Health Professions, 19, 208–230.CrossRefGoogle Scholar
  20. Fitzgerald, J. T., Anderson, R. M., Funnell, M. M., et al. (1998). The reliability and validity of a brief diabetes knowledge test. Diabetes Care, 21, 706–710.CrossRefPubMedGoogle Scholar
  21. Fuller, R., Nopoulos, P., Arndt, S., O’Leary, D., Ho, B. C., & Andreasen, N. C. (2002). Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. American Journal of Psychiatry, 159, 1183–1189.CrossRefPubMedGoogle Scholar
  22. Harmatz, M. G., & Lapuc, P. (1968). Behavior modification of overeating in a psychiatric population. Journal of Consulting and Clinical Psychology, 32, 583–587.CrossRefPubMedGoogle Scholar
  23. Harvey, P. D., Moriarty, P. J., Friedman, J. I., White, L., Parrella, M., Mohs, R. C., et al. (2000). Differential preservation of cognitive functions in geriatric patients with lifelong chronic schizophrenia: Less impairment in reading compared with other skill areas. Society of Biological Psychiatry, 47, 962–968.CrossRefGoogle Scholar
  24. Hayes, R. L., & O’Grady, B. M. (2003). Do people with schizophrenia comprehend what they read? Schizophrenia Bulletin, 29, 499–507.PubMedGoogle Scholar
  25. Henderson, D. C. (2005). Schizophrenia and comorbid medical disorders. Journal of Clinical Psychiatry, 66, 11–20.PubMedCrossRefGoogle Scholar
  26. Henderson, D. C., Cagliero, E., Copeland, P. M., Borba, C. P., Ervins, E., Hayden, D., et al. (2005). Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: A frequently sampled intravenous glucose tolerance test and minimal model analysis. Archives of General Psychiatry, 62, 19–28.CrossRefPubMedGoogle Scholar
  27. Henderson, D. C., Nguyen, D. D., Copeland, P. M., Hayden, D. L., Borba, C. P., Louie, et al. (2005). Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: Results of a 10-year naturalistic study. Journal of Clinical Psychiatry, 66, 1116–1121.PubMedCrossRefGoogle Scholar
  28. Holt, R. I., Bushe, C., & Citrome, L. (2005). Diabetes and schizophrenia 2005: Are we any closer to understanding the link? Journal of Psychopharmacology, 19, 56–65.CrossRefPubMedGoogle Scholar
  29. Jablensky, A., McGrath, J., Herrman, H., Castle, D., Gureje, O., Morgan, V., et al. (1999). People living with psychotic illness: An Australian study 1997–98. Commonwealth of Australia.Google Scholar
  30. Kopelowicz, A., Zarate, R., Gonzalez Smith, V., Mintz, J., & Liberman, R. P. (2003). Disease management in Latinos with schizophrenia: A family-assisted, skills training approach. Schizophrenia Bulletin, 29, 211–217.PubMedGoogle Scholar
  31. Lamberti, J. S., Crilly, J. F., Maharaj, K., Olson, D., Wiener, K., Dvorin, S., et al. (2004). Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs. Journal of Clinical Psychiatry, 65, 702–706.PubMedCrossRefGoogle Scholar
  32. Leslie, D. L., & Rosenheck, R. A. (2004). Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. American Journal of Psychiatry, 161, 1709–1711.CrossRefPubMedGoogle Scholar
  33. Lindamer, L., McKibbin, C. L., Jin, H., Ueki, K., & Jeste, D. V. (2006). Physical activity in middle-age and older patients with schizophrenia. Paper Presented at the meeting of the American Association for Geriatric Psychiatry, San Juan, Puerto Rico.Google Scholar
  34. Littrell, K. H., Hilligoss, N. M., Kirshner, C. D., Petty, R. G., & Johnson, C. G. (2003). The effects of an educational intervention on antipsychotic-induced weight gain. Journal of Nursing Scholarship, 35, 237–241.CrossRefPubMedGoogle Scholar
  35. Loh, C., Meyer, J. M., & Leckband, S. G. (2006). A comprehensive review of behavioral interventions for weight management in schizophrenia. Annals of Clinical Psychiatry, 18, 18–31.CrossRefGoogle Scholar
  36. Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., et al. (2004). Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry, 161, 1334–1349.CrossRefPubMedGoogle Scholar
  37. Mausbach, B. T., Bucardo, J., Cardenas, V., McKibbin, C., Barrio, C., Goldman, S. R., et al. (in press). Evaluation of a culturally tailored skills intervention for Latinos with persistent psychotic disorders. American Journal of Psychiatric Rehabilitation.Google Scholar
  38. McCreadie, R. G., Kelly, C., Connolly, M., Williams, S., Baxter, G., Lean, M., et al. (2005). Dietary improvement in people with schizophrenia: Randomised controlled trial. British Journal of Psychiatry, 187, 346–351.CrossRefPubMedGoogle Scholar
  39. McCreadie, R., Macdonald, E., Blacklock, C., Tilak-Singh, D., Wiles, D., Halliday, J., et al. (1998). Dietary intake of schizophrenic patients in Nithsdale, Scotland: Case–control study. British Medical Journal, 317, 784–785.PubMedGoogle Scholar
  40. McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., et al. (2005). Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research, 80, 19–32.CrossRefPubMedGoogle Scholar
  41. McKibbin, C. L., Lindamer, L., Sirkin, A., Jin, H., Ueki, K., Patterson, T., et al. (2006). Dietary habits in middle-aged and elderly patients with schizophrenia. Paper Presented at the meeting of the American Association for Geriatric Psychiatry, San Juan, Puerto Rico.Google Scholar
  42. McKibbin, C. L., Patterson, T. L., Norman, G., Patrick, K., Jin, H., Roesch, S., et al. (2006). A lifestyle intervention for older schizophrenia patients with Diabetes Mellitus: A randomized controlled trial. Schizophrenia Research, 86, 36–44.CrossRefPubMedGoogle Scholar
  43. Miller, C. K., Edwards, L., Kissling, G., & Sanville, L. (2002). Evaluation of a theory-based nutrition intervention for older adults with diabetes mellitus. Journal of American Dietary Association, 102, 1069–1081.Google Scholar
  44. Mukherjee, S., Schnur, D. B., & Reddy, R. (1989). Family history of type 2 diabetes in schizophrenic patients. Lancet, 1, 495.CrossRefPubMedGoogle Scholar
  45. Newcomer, J. W. (2005). Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review. CNS Drugs, 19, 1–93.CrossRefPubMedGoogle Scholar
  46. Patterson, T. L., Bucardo, J., McKibbin, C. L., Mausbach, B. T., Moore, D., Barrio, C., et al. (2005). Development and pilot testing of a new psychosocial intervention for older Latinos with chronic psychosis. Schizophrenia Bulletin, 31, 922–930.CrossRefPubMedGoogle Scholar
  47. Patterson, T. L., McKibbin, C. L., Taylor, M. J., Goldman, S., Davila-Fraga, W., Bucardo, J., et al. (2003). Functional Adaptation Skills Training (FAST): A pilot psychosocial intervention study in middle-aged and older patients with chronic psychotic disorders. American Journal of Geriatric Psychiatry, 11, 17–23.PubMedGoogle Scholar
  48. Radomile, R. R. (2000). Obesity. In J. R. White & A. S. Freeman (Eds.), Cognitive-behavioral group therapy for specific problems and populations (pp. 99–126). Washington, DC: American Psychological Association.CrossRefGoogle Scholar
  49. Rotatori, A. F., Fox, R., & Wicks, A. (1980). Weight loss with psychiatric residents in a behavioral self control program. Psychological Reports, 46, 483–486.PubMedGoogle Scholar
  50. Strassnig, M., Brar, J. S., & Ganguli, R. (2003). Nutritional assessment of patients with schizophrenia: A preliminary study. Schizophrenia Bulletin, 29, 393–397.PubMedGoogle Scholar
  51. Telles, C., Karno, M., & Mintz, J. (1995). Immigrant families coping with schizophrenia: Behavioral family intervention v. case management with a low-income Spanish speaking population. British Journal of Psychiatry, 167, 473–479.CrossRefPubMedGoogle Scholar
  52. US Census Bureau. (2000).
  53. Velligan, D. I., Kern, R. S., & Gold, J. M. (2006). Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies. Schizophrenia Bulletin, 32, 474–485.CrossRefPubMedGoogle Scholar
  54. Weber, M., & Wyne, K. (2006). A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophrenia Research, 83, 95–101.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Christine L. McKibbin
    • 1
  • David Folsom
    • 1
  • Jonathan Meyer
    • 1
  • A'verria Sirkin
    • 1
  • Catherine Loh
    • 1
  • Laurie Lindamer
    • 1
  1. 1.Veterans Affairs San Diego Healthcare SystemUniversity of California, San DiegoSan DiegoUSA

Personalised recommendations